VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today...
Nusano to Present at William Blair Virtual Radiopharmaceuticals Event
read more
News
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
Image above: Starget Pharma, stargetpharma.comVALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a...
Nusano Presenting at Industry Events in October
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today...
Nusano Adds to Executive Leadership Team in Advance of 2025 Commercialization
VALENCIA, Calif. – Oct. 3, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial...
Nusano Named to Insights Care 5 Most Trusted Radiopharmaceutical Companies to Watch
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its "5 Most Trusted Radiopharmaceutical...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates